Global Health

Support More Work Like This.

Your contribution makes it possible for the Center’s researchers to devise practical, evidence-based solutions for today’s most pressing development challenges.

Donate

As more countries rise out of poverty, CGD is focusing on the inequities and emerging problems that jeopardize global health progress: How should governments allocate scarce health budgets rationally? How can global health donors and other development partners advance global health security, pandemic preparedness, and health systems strengthening? What can be done to address health inequities in low- and middle-income countries? What are evidence-informed policies to address market failures that span from early-stage pharmaceutical research and development to supply chain efficiency and ensure health product markets work for the poor? 

CGD research helps policymakers build sustainable health systems, respond to shifting realities, and deliver value for money.

Program Goals

CGD’s Global Health Policy program analyzes the economics of global health challenges, offering practical policy solutions to shape decision-making by policymakers within global health institutions, donor organizations, and governments.  

CGD examines the efficiency and effectiveness of global health practices to expand access, drive greater value-for-money, and align incentives to support global public goods for health – with a particular focus on advancing the equitable provision of essential, quality health services in low- and middle-income countries.

02
An Indian pharmacist pulls out a box of medicines from a shelf at a Generic Drug Store at the Victoria Hospital in Bangalore on June 28, 2012. The Generic Drug Store which was opened in Bangalore recently by the medical education department in association with the Karnataka State Cooperative Consumer Federation sells branded generic drugs which are priced less than 50 percent of the Maximum Retail Price (MRP). Estimates by Dolat Capital show that the US generic market, currently estimated at USD350 billion
Improving global health procurement, supply chains, and innovation in health product markets

CGD’s analysis supports donors and low- and middle-income countries to implement policies to build supply chain efficiency and resilience. In addition, CGD explores how US government agencies can use “pull mechanisms” to support high-impact R&D innovation for the benefit low-income countries.

04
Vital stats on a computer in a hospital; medical professionals in the background
Strengthening priority-setting and value-for-money at the national, regional, and global levels

CGD provides tailored advice to select low- and middle-income countries, regional bodies, and global health entities with the aim of increasing value for money in their health investments by advancing the evidence-based priority setting field. 

06
Lead paint warning sign
Eradicating the global burden of lead poisoning

CGD aims to increase awareness, salience, and prioritization of lead poisoning at global and local levels to mitigate the burden of lead, especially in low- and middle-income countries.

01
In this image, a relieved little African girl is looked after by the vaccination staff after she has received her first Covid shot. Source: Riccardo Mayer
Advancing equitable access to, and appropriate use of, safe, effective, quality-assured medical countermeasures – lessons learned from COVID-19

CGD provides high-impact research and policy advice to low- and middle-income governments to efficiently procure affordable supplies of cost-effective medical countermeasures, including oral antivirals, vaccines, oxygen, and PPE, in line with national priorities and targets. 

03
Quality Control Laboratory medicine
Rethinking pandemic preparedness and global health security for the post-COVID-19 era

CGD supports the operationalization of the Pandemic Fund to improve effective financing arrangements of pandemic preparedness in low- and middle-income countries. CGD’s analysis also focuses on improving access, innovations, and stewardship for antimicrobials, and informing the current discourse on building more distributed vaccine manufacturing in low- and middle-income countries.  

05
Cigarette butts crushed into ground, with a scotch glass full in the background
Strengthening resilience and sustainability of health financing in the face of fiscal pressures

CGD’s research looks at how low- and middle-income countries can strengthen health financing and introduce policies to improve resilience and sustainability of health systems. This includes the design and implementation of effective taxes on tobacco, alcohol, and sugar-sweetened beverages.

Program Goals

CGD’s Global Health Policy program analyzes the economics of global health challenges, offering practical policy solutions to shape decision-making by policymakers within global health institutions, donor organizations, and governments.  

CGD examines the efficiency and effectiveness of global health practices to expand access, drive greater value-for-money, and align incentives to support global public goods for health – with a particular focus on advancing the equitable provision of essential, quality health services in low- and middle-income countries.

01
In this image, a relieved little African girl is looked after by the vaccination staff after she has received her first Covid shot. Source: Riccardo Mayer
Advancing equitable access to, and appropriate use of, safe, effective, quality-assured medical countermeasures – lessons learned from COVID-19

CGD provides high-impact research and policy advice to low- and middle-income governments to efficiently procure affordable supplies of cost-effective medical countermeasures, including oral antivirals, vaccines, oxygen, and PPE, in line with national priorities and targets. 

02
An Indian pharmacist pulls out a box of medicines from a shelf at a Generic Drug Store at the Victoria Hospital in Bangalore on June 28, 2012. The Generic Drug Store which was opened in Bangalore recently by the medical education department in association with the Karnataka State Cooperative Consumer Federation sells branded generic drugs which are priced less than 50 percent of the Maximum Retail Price (MRP). Estimates by Dolat Capital show that the US generic market, currently estimated at USD350 billion
Improving global health procurement, supply chains, and innovation in health product markets

CGD’s analysis supports donors and low- and middle-income countries to implement policies to build supply chain efficiency and resilience. In addition, CGD explores how US government agencies can use “pull mechanisms” to support high-impact R&D innovation for the benefit low-income countries.

03
Quality Control Laboratory medicine
Rethinking pandemic preparedness and global health security for the post-COVID-19 era

CGD supports the operationalization of the Pandemic Fund to improve effective financing arrangements of pandemic preparedness in low- and middle-income countries. CGD’s analysis also focuses on improving access, innovations, and stewardship for antimicrobials, and informing the current discourse on building more distributed vaccine manufacturing in low- and middle-income countries.  

04
Vital stats on a computer in a hospital; medical professionals in the background
Strengthening priority-setting and value-for-money at the national, regional, and global levels

CGD provides tailored advice to select low- and middle-income countries, regional bodies, and global health entities with the aim of increasing value for money in their health investments by advancing the evidence-based priority setting field. 

05
Cigarette butts crushed into ground, with a scotch glass full in the background
Strengthening resilience and sustainability of health financing in the face of fiscal pressures

CGD’s research looks at how low- and middle-income countries can strengthen health financing and introduce policies to improve resilience and sustainability of health systems. This includes the design and implementation of effective taxes on tobacco, alcohol, and sugar-sweetened beverages.

06
Lead paint warning sign
Eradicating the global burden of lead poisoning

CGD aims to increase awareness, salience, and prioritization of lead poisoning at global and local levels to mitigate the burden of lead, especially in low- and middle-income countries.